BioMarin
SAN RAFAEL · Biotechnology, Genetics, Health Care
Founded in 1997, BioMarin is a global biotechnology company dedicated to transforming lives through genetic discovery. The company develops and commercializes targeted therapies that address the root cause of genetic conditions. BioMarin's unparalleled research and development capabilities have resulted in eight transformational commercial therapies for patients with rare genetic disorders. The co
Key facts
- Headquarters
- SAN RAFAEL
- Employees
- Unknown
- Industries
- Biotechnology, Genetics, Health Care
- Status
- Public (BMRN)
- Website
- biomarin.hr
- Company page
BioMarin in the news
- BioMarin Announces Five-Year Phase 3 Data for POMBILITI® (cipaglucosidase alfa-atga) + OPFOLDA® (miglustat) at World Muscle Society Annual Congress - PR Newswire (Oct 02, 2026)
- Fierce Biotech Layoff Tracker 2026: Foghorn cuts workforce by 40%; BioMarin drops 117 roles - Fierce Biotech (Oct 01, 2026)
- Profluent Partners With BioMarin to Design Novel Medicines Using AI - BioSpace (Sep 30, 2026)
- BioMarin consolidates staff at Amicus HQ after closing $4.8B deal for rare disease peer - Fierce Pharma (May 12, 2026)
- BioMarin acquires Amicus Therapeutics for $4.8bn - Pharmaceutical Technology (Apr 28, 2026)
- BioMarin Announces Appointment of Robert Plenge, M.D., Ph.D., Chief Research Officer of Bristol Myers Squibb, to Board of Directors - PR Newswire (Sep 14, 2026)
- BioMarin discontinues rare disease drug; CSL and Arcturus split up - endpoints.news (Aug 07, 2026)
- BioMarin suffers another blow to rare disease portfolio in Phase 3 flop - BioSpace (May 19, 2026)
Companies similar to BioMarin
- Agendia · Biotechnology, Genetics, Health Care, Medical, Therapeutics
- Vico Therapeutics · Biotechnology, Genetics, Health Care, Medical, Therapeutics
- Modalis Therapeutics Corporation · Biotechnology, Genetics, Health Care, Medical, Therapeutics
- Elevation Oncology · Biotechnology, Genetics, Health Care, Medical, Therapeutics
- 4D Molecular Therapeutics · Biotechnology, Genetics, Health Care, Medical, Therapeutics
About BioMarin: questions and answers
What does BioMarin do?
Founded in 1997, BioMarin is a global biotechnology company dedicated to transforming lives through genetic discovery. The company develops and commercializes targeted therapies that address the root cause of genetic conditions. BioMarin's unparalleled research and development capabilities have resulted in eight transformational commercial therapies for patients with rare genetic disorders. The co
Where is BioMarin headquartered?
BioMarin is headquartered in SAN RAFAEL.
Is BioMarin a public company?
Yes. BioMarin is publicly traded under the ticker BMRN.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy